THIAZIDE& THIAZIDE LIKE DIURETICS
This group of agents includes thiazides, containing a
benzothiadiazine molecular structure, and also thiazide-like drugs with similar
actions but without the benzothiadiazine structure, including chlortha-lidone
(Thalitone), quinethazone (Hydromox), metolazone (Zaroxolyn), and indapamide
(Lozol). These diuretics act at the distal tubule, including the connecting
segment, and inhibition of sodium reabsorption at this site impairs diluting
but not concentrating ability. They compete for the Cl −
site on the luminal Na+–Cl −
carrier protein. When given alone, thiazide and thiazide-like diuretics
increase Na+ excretion to only 3–5% of the filtered load because of enhanced
compensatory Na+ reab-sorption in the collecting tubules. They also possess carbonic
anhydrase–inhibiting activity in the prox-imal tubule, which is usually masked
by sodium reabsorption in the loop of Henle and which is probably responsible
for the marked diuresis often seen when they are combined with loop diuret-ics.
In contrast to their effects on sodium excre-tion, thiazide and thiazide-like
diuretics augment Ca2+
reabsorption in the distal tubule. Indapamide has some vasodilating properties
and is the only thiazide or thiazide-like diuretic with significant hepatic
excretion.
Th iazide and thiazide-like diuretics
are often selected as first-line agents in the treatment of hyperten-sion , and
they have been shown to improve long-term outcomes in this disorder.
Th ese drugs are used to treat mild to moderate edema and
congestive heart failure related to mild to moderate sodium overload.
Th iazide and thiazide-like diuretics are often used to decrease
calcium excretion in patients with hyper-calciuria who form renal stones.
The efficacy of these agents in this disorder reflects their
ability to impair diluting capacity and increase urine osmolality .
Th ese agents are only given orally.
Although thiazide and thiazide-like
diuretics deliver less sodium to the collecting tubules than loop diuretics,
the increase in sodium excretion is enough to enhance K +
secretion and frequently results in hypokalemia. Enhanced H+
secretion can also occur, resulting in metabolic alkalosis. Impairment of renal
diluting capacity may produce hyponatremia. Hyperuricemia, hyperglycemia,
hypercalcemia, and hyperlipidemia may also be seen.
Related Topics
Privacy Policy, Terms and Conditions, DMCA Policy and Compliant
Copyright © 2018-2023 BrainKart.com; All Rights Reserved. Developed by Therithal info, Chennai.